Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TGM2 | P21980 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3208190 | 0.83 | MAPT (0.38) | MAPTGAASMN1; SMN2RAB9AP2RX4 | |
| Lithium Ion SCHEMBL984533 | 0.83 | MAPT (0.38) | MAPTGAASMN1; SMN2RAB9AP2RX4 | |
| SCHEMBL31448339 | 0.79 | MAPT (0.43) | MAPTGAASMN1; SMN2RAB9AP2RX4 | |
| SCHEMBL28059865 | 0.79 | MAPT (0.43) | MAPTGAASMN1; SMN2RAB9AP2RX4 | |
| SCHEMBL1284871 | 0.78 | CES1 (0.36) | SMN1; SMN2ALDH1A1MEN1TP53KMT2A | |
| SCHEMBL4796337 | 0.77 | MAPT (0.42) | MAPTGAASMN1; SMN2RAB9AP2RX4 | |
| SCHEMBL29896250 | 0.77 | MAPT (0.42) | MAPTGAASMN1; SMN2RAB9AP2RX4 | |
| SCHEMBL9782872 | 0.76 | MAPT (0.41) | MAPTGAASMN1; SMN2RAB9AP2RX4 | |
| SCHEMBL3912413 | 0.75 | MAPT (0.39) | MAPTGAASMN1; SMN2RAB9AP2RX4 | |
| SCHEMBL1285713 | 0.74 | MAPT (0.46) | MAPTGAASMN1; SMN2RAB9AP2RX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070254183-A1 | Electroluminescent materials and deivces | MERCK PATENT GMBH (DE) | 2007-11-01 | — | — | US | claimed |
| CN-119856682-A | Creation and identification method of macadimia nut excellent drought-enduring germplasm | 广西壮族自治区亚热带作物研究所（广西亚热带农产品加工研究所） | 2025-04-22 | — | — | CN | disclosed |
| CN-111183192-B | Antistatic powder coating composition | 株式会社KCC | 2022-06-07 | — | — | CN | disclosed |
| CN-111183129-A | Novel anthranilic acid compound, Pin1 inhibitor using same, and therapeutic agent for inflammatory disease and cancer | 国立大学法人广岛大学 | 2020-05-19 | — | — | CN | disclosed |
| US-8507896-B2 | Compounds having electroluminescent or electron transport properties | MERCK PATENT GMBH (DE) | 2013-08-13 | — | — | US | disclosed |
| US-20110006295-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | MERCK PATENT GMBH | 2011-01-13 | — | — | US | disclosed |
| EP-2250151-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | Merck Patent GmbH (DE) | 2010-11-17 | — | — | EP | disclosed |
| WO-2009112854-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | MERCK PATENT GMBH (DE) | 2009-09-17 | — | — | WO | disclosed |
| CN-1233180-A | Treatment of the common cold or allergic rhinitis | LILLY CO ELI (US) | 1999-10-27 | — | — | CN | disclosed |
| EP-0490200-B1 | Derivatives of quinoline carboxylic acid | BASF AG (DE) | 1996-02-28 | — | — | EP | disclosed |
| EP-0388620-B1 | Process for the preparation of o-carboxypyridyl- and o-carboxyquinolylimidazolinones | AMERICAN CYANAMID CO (US) | 1994-11-02 | — | — | EP | disclosed |
| US-5214146-A | Color formers for pressure sensitive recording materials | BASF AKTIENGESELLSCHAFT (DE) | 1993-05-25 | — | — | US | disclosed |
| EP-0388620-A1 | Process for the preparation of o-carboxypyridyl- and o-carboxyquinolylimidazolinones | AMERICAN CYANAMID COMPANY (US) | 1990-09-26 | — | — | EP | disclosed |
| US-4925944-A | CONDENSATION AND CYCLIZATION IN AROMATIC SOLVENT AND SULFUR; ONE STEP; HERBICIDES | AMERICAN CYANAMID COMPANY (US) | 1990-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110006295-A1 | COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES | NR2E3, NR4A2, NR4A3 | MAPT 3534/4885GAA 4048/4885SMN1; SMN2 1611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.